Home › Attention Deficit Hyperactivity Disorder › Virginia › Richmond
Attention Deficit Hyperactivity Disorder clinical trials in Richmond, VA
3 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Petersburg · 23 mi away
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Petersburg · 23 mi away
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Virginia Commonwealth University, Virginia Treatment Center for Children, Richmond
- Clinical Research Partners, LLC, Petersburg · 23 mi away
About Attention Deficit Hyperactivity Disorder
Attention deficit hyperactive disorder (ADHD) is a neurodevelopmental disorder. Its main symptoms are inattention, hyperactivity, and impulsivity. Learn more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX7 studies
- Philadelphia, PA6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA5 studies
- Portland, OR5 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Baltimore, MD4 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.